By Ashley Gardyne, Senior Portfolio Manager
07 February, 2017
Are you are reading this on a digital screen — your mobile, tablet or PC?
Studies show that people are spending more and more time staring at digital devices. In the US, the average person now spends over 10 hours a day staring at a screen. With that in mind, it may not surprise you that an increasing number of people are experiencing deteriorating vision.
But fear not — French company Essilor "Your vision is our mission" — which we have recently invested in, has a solution to this. Essilor produces lenses that block the damaging blue light from digital screens and subsequently reduces eye strain. While it may not sound revolutionary on its own, Essilor has a history of innovation in optical lenses and developments such as polarisation, transition lenses, progressive lenses and anti-reflectives.
Over time there has been a trend towards premiumisation of lenses as the benefits of the features above are better understood. As a result, Essilor has steadily increased the prices of its lenses and grown its profitability. They control 40% of the lens industry; and through innovation and market consolidation their operating earnings have grown at 11% pa over the past 10 years.
In January, Essilor announced a merger with Luxottica, which in our opinion demonstrates sound strategic thinking. Luxottica is the Italian eyewear frames manufacturer that owns Ray-Ban and Oakley. They also manufacture frames for luxury houses like Prada, Armani and Chanel and they're the world's largest eyewear retailer through their OPSM, Sunglass Hut and LensCrafters chains. Despite the obvious complementary nature of the products, lenses and frames have generally been manufactured by different companies, until now.
There is no doubt the merger creates an industry heavyweight and a leading platform in an attractive market. With it estimated that over half of people requiring vision correction still go untreated, combined with the trend towards premiumisation in lenses and sunglasses, we see a long growth runway. The merger highlights a clear long term vision for EssilorLuxottica.
Click here to take Essilor's quick online eye test.
Subscribe to receive
our monthly newsletter
Disclaimer: Fisher Funds Management Limited ("Fisher Funds") is the issuer of the financial products referred to on this website. A replacement PDS for each of the financial products is available here and also on the relevant scheme's offer register entry at companiesoffice.govt.nz/disclose. The information, calculations and any opinions on this website are based upon sources believed reliable, but Fisher Funds, its officers and directors make no representations as to their accuracy or completeness. All opinions reflect our judgment on the date of communication and are subject to change without notice. Professional investment advice should be taken before making an investment. Past performance is not a reliable guide to future performance. A disclosure statement is available from your financial adviser, on request and free of charge.
© 2017 Fisher Funds - Website Design & Development 3webfeet Limited
Is there anything we
can help you with?